Response to Comments: Molecular RBC Phenotyping

This notice documents that CGS Administrators received no comments on DL36011 (Molecular RBC Phenotyping) during the comment period. It does not add, change, or specify any coverage criteria, limitations, documentation, or frequency rules; coverage remains as specified in the underlying policy DL36011. No new actionable criteria are contained in this document.